Skip to content

ARROWHEAD PHARMACEUTICALS, INC.: 10-Q filed 2013-02-13

What ARROWHEAD PHARMACEUTICALS, INC. reported in its quarterly report filed 2013-02-13 (fiscal Q1 2013): 34 published measures, 105 facts as tagged in accession 0001193125-13-055330.

This filing

Form
10-Q (quarterly report)
Filed
2013-02-13
Fiscal period
fiscal Q1 2013
Accession
0001193125-13-055330 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARROWHEAD PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3115,231,131USD
At 2012-09-3016,527,818USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-318,974,780USD
At 2012-09-3010,012,642USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-312,931,032USD
At 2012-09-303,377,288USD
At 2011-12-316,773,126USD
At 2011-09-307,507,389USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-4,614,159USD92
2003-05-01 to 2012-12-31-139,447,879USD3533
2011-10-01 to 2011-12-31-2,485,505USD92
2004-10-01 to 2005-09-30-6,733,427USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-10-01 to 2012-12-319,439USD92
2003-05-01 to 2012-12-314,054,748USD3533
2011-10-01 to 2011-12-3169,424USD92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-10-01 to 2012-12-31159,016USD92
2003-05-01 to 2012-12-314,297,850USD3533
2011-10-01 to 2011-12-3123,958USD92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-139,611,839USD
At 2012-09-30-134,997,680USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-0.33USD/shares92
2011-10-01 to 2011-12-31-0.25USD/shares92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-314,426,683USD
At 2012-09-304,895,652USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-10-01 to 2012-12-31395,675USD92
2003-05-01 to 2012-12-3113,977,143USD3533
2011-10-01 to 2011-12-31251,878USD92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-4,810,021USD92
2003-05-01 to 2012-12-31-122,026,034USD3533
2011-10-01 to 2011-12-31-4,039,039USD92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-316,063,983USD
At 2012-09-306,567,336USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-316,077,978USD
At 2012-09-305,327,888USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-31809,524USD
At 2012-09-30877,986USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-12-311,593,132USD
At 2012-09-301,667,247USD
At 2011-09-301,731,211USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-31115,266USD
At 2012-09-309,375USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-10-01 to 2012-12-314,969,037USD92
2003-05-01 to 2012-12-31126,323,884USD3533
2011-10-01 to 2011-12-314,062,997USD92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-10-01 to 2012-12-311,576,666USD92
2003-05-01 to 2012-12-3144,195,414USD3533
2011-10-01 to 2011-12-31769,074USD92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3115,644,158shares
At 2012-09-3013,579,185shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-12-317,604,479USD
At 2012-09-308,808,909USD
At 2011-09-3012,564,167USD
At 2010-09-308,078,295USD
At 2009-09-304,857,936USD
At 2008-09-3012,302,609USD
At 2007-09-3026,456,577USD
At 2006-09-3031,605,644USD
At 2005-09-3028,026,657USD
At 2004-09-3011,227,149USD
At 2003-09-301,419,762USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-316,367,948USD
At 2012-09-306,461,435USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-311,941,265USD
At 2012-09-301,565,783USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-314,740,465USD
At 2012-09-305,064,830USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-31270,931USD
At 2012-09-30269,142USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-31842,639USD
At 2012-09-30730,775USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-31460,922USD
At 2012-09-30618,130USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-4,780,709USD92
2003-05-01 to 2012-12-31-115,595,660USD3533
2011-10-01 to 2011-12-31-2,686,579USD92

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-4,780,727USD92
2003-05-01 to 2012-12-31-158,433,732USD3533
2011-10-01 to 2012-09-30-22,110,723USD366
2011-10-01 to 2011-12-31-2,686,799USD92
2010-10-01 to 2011-09-30-3,492,399USD365
2009-10-01 to 2010-09-30-6,957,038USD365
2008-10-01 to 2009-09-30-19,308,392USD365
2007-10-01 to 2008-09-30-27,241,639USD366
2006-10-01 to 2007-09-30-30,712,947USD365
2005-10-01 to 2006-09-30-19,961,961USD365
2003-10-01 to 2004-09-30-751,255USD366
2002-10-01 to 2003-09-30-95,238USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-31917,676USD92
2003-05-01 to 2012-12-3132,270,891USD3533
2011-10-01 to 2011-12-311,266,908USD92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-10-01 to 2012-12-31449,597USD92
2003-05-01 to 2012-12-317,858,883USD3533
2011-10-01 to 2011-12-31454,444USD92

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-10-01 to 2012-12-3174,115USD92
2011-10-01 to 2012-09-30293,964USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-10-01 to 2012-12-3129,312USD92
2003-05-01 to 2012-12-316,430,374USD3533
2011-10-01 to 2011-12-311,352,461USD92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-10-01 to 2012-12-313,332,467USD92
2003-05-01 to 2012-12-31109,585,478USD3533
2012-07-11 to 2012-08-106,200,000USD31
2011-10-01 to 2011-12-311,463,833USD92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-68,459USD92
2003-05-01 to 2012-12-31429,851USD3533
2011-10-01 to 2011-12-31137,448USD92

Inspect the source

Entity
ARROWHEAD PHARMACEUTICALS, INC. / CIK 0000879407
Captured
2026-09-20T05:01:27.924Z
SEC response SHA-256
df8855dae0055b71bd49c85d7ebc47f72ea6d71536d6bfd857bed2fe95364863

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000879407.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))